Andrea Cassingena

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Author Correction: The genomic landscape of response to EGFR blockade in colorectal cancer.

Author Correction: The genomic landscape of response to EGFR blockade in colorectal cancer.

Journal: Nature
Published: February 16, 2026

Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.

Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.

Journal: Cancer discovery
Published: November 01, 2021

Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment.

Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 30, 2021

Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids.

Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids.

Journal: JCO precision oncology
Published: April 07, 2021

Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ.

Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ.

Journal: Nature communications
Published: July 21, 2020

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.

Journal: Clinical colorectal cancer
Published: March 20, 2020

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients.

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients.

Journal: ESMO open
Published: August 02, 2019

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2019

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 20, 2018

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.

Journal: Cancer cell
Published: February 18, 2018

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.

Journal: Targeted oncology
Published: July 03, 2017

Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.

Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 04, 2017
Showing 1-12 of 25

Last Updated: 09/26/2026